← ANALYSTS · TIPRANKS
Seamus Fernandez · Guggenheim
Hits
66%
232 of 352 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+30.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
15
Buy / hold / sell: 13 / 2 / 0
Upside of the analyst’s targets
+134.7%
Average over 13 current targets, to the last price
The market’s answer to the ratings
+6.9%
Day-0 move against SPY in the rating’s direction, average over 9 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 07:30 | MBXIWMMBX Biosciences, Inc. · $2.4B | Reiterated | Buy | $150 | +202.4% | −2.2%next day −5.8% | ↗ |
| Oct 8on TipRanks Oct 9 08:50 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $75.00 | +25.5% | +0.2%next day −1.4% · 5 days +1.9% | ↗ |
| Oct 5on TipRanks 07:16 | PCVXIWMVaxcyte · $10.3B | Reiterated | Buy | $116 → $125+7.8% | +96.5% | +30.0%next day −10.2% · 5 days −4.7% | ↗ |
| Oct 2on TipRanks 06:55 | MBXIWMMBX Biosciences, Inc. · $2.4B | Assigned | Buy | $88.00 → $150+70.5% | +202.4% | +2.7%next day −0.6% · 5 days −10.2% | ↗ |
| Oct 1on TipRanks Oct 2 06:55 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $25.00 → $26.00+4.0% | +224.2% | −5.3%next day −3.2% · 5 days −6.1% | ↗ |
| Sep 28on TipRanks Sep 29 06:50 | IVAInventiva · $877M | Reiterated | Buy | $14.00 | +376.2% | +5.5%next day −6.6% · 5 days −2.6% | ↗ |
| Sep 17on TipRanks Sep 18 07:10 | LLYSPYEli Lilly & Co · $1.2T | Reiterated | Buy | $1,273 → $1,284+0.9% | +2.1% | +0.2%next day −0.1% · 5 days +1.7% | ↗ |
| Aug 31on TipRanks 06:20 | TENXIWMTenax Therapeutics · $57M | Downgrade | Hold | — | — | −13.3%next day −1.5% · 5 days +7.8% | ↗ |
| Aug 26on TipRanks Aug 27 07:10 | AMLXIWMAmylyx Pharmaceuticals Inc · $3.4B | Assigned | Buy | $55.00 → $57.00+3.6% | +116.4% | −1.0%next day −0.4% · 5 days −6.9% | ↗ |
| Aug 24on TipRanks Aug 25 06:50 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Reiterated | Buy | $143 | +66.0% | +1.6%next day +1.4% · 5 days −5.2% | ↗ |
| Aug 12on TipRanks Aug 13 07:10 | MLYSIWMMineralys Therapeutics, Inc. · $1.9B | Reiterated | Buy | $52.00 | +156.2% | −1.3%next day −4.2% · 5 days +0.1% | ↗ |
| Aug 12on TipRanks 07:10 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $25.00 | +211.7% | −1.6%next day −1.9% · 5 days +13.1% | ↗ |
| Aug 11on TipRanks 06:55 | SEPNIWMSepterna, Inc. · $1.7B | Reiterated | Buy | $45.00 → $51.00+13.3% | +40.3% | +23.3%next day +0.6% · 5 days −7.9% | ↗ |
| Aug 6on TipRanks Aug 7 08:01 | ARCTIWMArcturus Therapeutics · $320M | Reiterated | Hold | — | — | −2.7%next day +21.3% · 5 days +28.1% | ↗ |
| Aug 5on TipRanks Aug 6 07:06 | PCVXIWMVaxcyte · $10.3B | Reiterated | Buy | $116 | +82.3% | +2.4%next day +5.5% · 5 days +6.3% | ↗ |
| Aug 5on TipRanks Aug 6 06:50 | ARQTIWMArcutis Biotherapeutics · $3.7B | Assigned | Buy | $35.00 → $38.00+8.6% | +31.9% | +4.3%next day −2.3% · 5 days −3.4% | ↗ |
| Jul 31on TipRanks 06:55 | BMYSPYBristol-Myers Squibb · $124B | Reiterated | Buy | $72.00 → $75.00+4.2% | +25.5% | 0.0%next day −1.2% · 5 days −4.4% | ↗ |
| Jul 14on TipRanks 07:10 | MBXIWMMBX Biosciences, Inc. · $2.4B | Reiterated | Buy | $88.00 | +77.4% | −6.1%next day +6.8% · 5 days +7.0% | ↗ |
| Jun 24on TipRanks Jun 25 07:50 | GENBIWMGenerate Biomedicines, Inc. · $1.6B | Reiterated | Buy | $30.00 | +148.1% | +5.2%next day +1.0% · 5 days 0.0% | ↗ |
| May 11on TipRanks 07:35 | ACRSIWMAclaris Therapeutics · $514M | Reiterated | Buy | $12.00 | +265.9% | +0.2%next day −1.3% · 5 days −11.0% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗